IP Library Granted Patent US 6,883,222
Granted Patent B2
US 6,883,222 · App. 10/272,689 · Granted Apr 26, 2005

Drug cartridge assembly and method of manufacture

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,883,222
App. No.
10/272,689
Granted
Apr 26, 2005
Kind
B2
Abstract

A method of manufacture for a drug cartridge assembly. The method includes providing a drug cartridge, providing a nozzle sub-assembly, and sterilizing the drug cartridge and nozzle sub-assembly. The method further includes assembling the drug cartridge and nozzle sub-assembly together in a configuration that enables ejection of liquid out of the drug cartridge through the nozzle sub-assembly. The method further includes filling the drug cartridge with a liquid, such as an injectable drug. The method may include separate sterilization of the drug cartridge and nozzle sub-assembly, using different sterilization processes. Portions of the method may be performed prior to sterilization within a first cleanroom, with subsequent steps being performed in a second cleanroom having a substantially lower particulate-per-volume rating than the first cleanroom.

Claims (31)

1. A method of preparing a sterile drug cartridge assembly, comprising:

providing a drug cartridge;

providing a nozzle sub-assembly, where the drug cartridge and nozzle-sub-assembly are adapted to be engaged together to enable ejection of liquid from the drug cartridge out through the nozzle sub-assembly;

assembling the nozzle subassembly and otherwise preparing the nozzle sub-assembly for sterilization in a first cleanroom;

sterilizing the nozzle sub-assembly;

sterilizing the drug cartridge; and

positioning the drug cartridge in a ready-to-use position within the nozzle sub-assembly, and filling and sealing the drug cartridge, where the positioning, filling and sealing are performed within a second cleanroom, the second cleanroom having a particulate-per-volume rating which is at least ten times lower than that of the first cleanroom.

2. The method of claim 1 , where preparing the nozzle sub-assembly includes providing a nozzle having a nozzle opening to accommodate ejection of liquid, and positioning a sealing mechanism adjacent the nozzle opening so that the sealing mechanism covers the nozzle opening.

3. The method of claim 1 , where sterilizing the nozzle sub-assembly is performed with a radiation-based sterilization process.

4. The method of claim 3 , where sterilizing the nozzle sub-assembly is performed using gamma radiation.

5. The method of claim 3 , where sterilizing the drug cartridge is performed with a thermal sterilization process, and is performed separately from sterilization of the nozzle sub-assembly.

6. The method of claim 1 , where sterilization of the nozzle sub-assembly and drug cartridge are performed separately using different sterilization processes.

7. The method of claim 1 , further comprising washing the drug cartridge.

8. The method of claim 1 , further comprising depyrogenizing the drug cartridge.

9. The method of claim 1 , further comprising siliconizing the drug cartridge.

10. The method of claim 1 , where sealing the drug cartridge includes securing a valve structure between an opening in the nozzle sub-assembly and an opening in the drug cartridge.

11. The method of claim 10 , where sealing the drug cartridge further includes disposing a plunger within another opening of the drug cartridge.

12. The method of claim 1 , where the first cleanroom is a class 10,000 cleanroom and the second cleanroom is a class 100 cleanroom.

13. A method of manufacturing a medical device, comprising:

separating a glass drug container of the medical device from another component of the medical device;

sterilizing the glass drug container separately from the other component of the medical device, where the glass drug container is sterilized with a thermal-based sterilization process, and where the other component is sterilized using a radiation-based sterilization process;

filling the glass drug container with a metered dose of an injectable drug;

assembling the glass drug container with the other component of the medical device; and

disposing the glass drug container and the other component of the medical device within a sterile package.

14. A method of manufacturing a sterile injection device, comprising:

providing a liquid container;

providing a nozzle sub-assembly, where the liquid container and nozzle-sub-assembly are adapted to be engaged together to enable ejection of liquid from the liquid container out through the nozzle sub-assembly;

preparing the nozzle sub-assembly for sterilization, where such preparation is performed in a first cleanroom;

sterilizing the nozzle sub-assembly via irradiation;

sterilizing the liquid container separately from the nozzle sub-assembly using a thermal sterilization process; and

securing the liquid container and nozzle sub-assembly together, and filling and sealing the liquid container, where the securing, filling and sealing are performed within a second cleanroom, the second cleanroom having a particulate-per-volume rating which is at least ten times lower than that of the first cleanroom.

Assignments (5)
MERGER Recorded Feb 2, 2021
From: GENETRONICS, INC.
To: INOVIO PHARMACEUTICALS, INC.
Reel/Frame 055114/0784 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2016
From: PARTNERS FOR GROWTH LP
To: BIOJECT MEDICAL TECHNOLOGIES INC. & BIOJECT INC.
Reel/Frame 038265/0229 →
SECURITY AGREEMENT Recorded Sep 4, 2007
From: BIOJECT, INC.
To: PARTNERS FOR GROWTH, L.P.
Reel/Frame 019773/0642 →
SECURITY AGREEMENT Recorded Dec 11, 2006
From: BIOJECT, INC.
To: PARTNERS FOR GROWTH, L.P.
Reel/Frame 018606/0671 →
SECURITY AGREEMENT Recorded Mar 29, 2006
From: BIOJECT, INC.
To: PARTNERS FOR GROWTH, L.P.
Reel/Frame 017379/0255 →